The Globe and Mail Adam Mayers Published February 8, 2021 NanoStockk/iStockPhoto / Getty Images Medical technology companies have been the stars of the health care sector for the past decade, but they met their match in 2020 when the COVID-19 pandemic arrived in full force. Lockdowns during the past spring led to cancelled elective surgeries and slowed the pace of necessary surgeries. Patients were afraid to visit hospitals for check-ups and less urgent needs. And while many of the companies in this space are global, that didn’t help as the pandemic affected all of their markets. That meant slim returns for investors. But with hopes that vaccinations will normalize conditions this year, is 2021 the year medtech bounces back?